ClinVar Miner

Submissions for variant NM_032119.4(ADGRV1):c.8161A>G (p.Ile2721Val)

gnomAD frequency: 0.00056  dbSNP: rs201963060
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039642 SCV000063331 likely benign not specified 2012-04-17 criteria provided, single submitter clinical testing p.Ile2721Val in exon 35 of GPR98: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. In addition, computational prediction tools do not suggest a high likelihood of im pact to the protein. It has been identified in 0.13% (60/38684) of European chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs201963060).
Eurofins Ntd Llc (ga) RCV000724489 SCV000229799 uncertain significance not provided 2015-01-21 criteria provided, single submitter clinical testing
GeneDx RCV000724489 SCV000978896 likely benign not provided 2020-06-25 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 32707200)
Labcorp Genetics (formerly Invitae), Labcorp RCV000724489 SCV001210534 likely benign not provided 2025-01-13 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001151661 SCV001312826 uncertain significance Usher syndrome type 2C 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
CeGaT Center for Human Genetics Tuebingen RCV000724489 SCV004032610 likely benign not provided 2023-10-01 criteria provided, single submitter clinical testing ADGRV1: BP4
Fulgent Genetics, Fulgent Genetics RCV005031478 SCV005666297 uncertain significance Usher syndrome type 2C; Febrile seizures, familial, 4 2024-03-13 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.